CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Hy2Care BV aims to provide a groundbreaking treatment for Osteoarthritis using injectable hydrogels made from advanced nanomaterials. These hydrogels improve tissue integration and have potential applications in various biomedical fields.
Hy2Care BV is a spin-off company of Twente University, in the Netherlands.
It is Hy2Care’s ambition to introduce the first cure to Osteoarthritis (OA).
The World Health Organization forecasted that, without treatment, OA will be the fourth leading cause of disability by 2020.
Today, there is still no adequate solution for more than 120 million patients worldwide.
Therefore OA represents a major economic burden on individuals, health care and social care systems.
Hy2Care’s Injectable hydrogels ar…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
